I think improving the overall policy is a big question. What I'd rather do is comment on a couple of really specific suggestions that we think could help add to what is already under way.
One of them is that right now we really need to look at the risk capital that's available in the ecosystem to grow deep IP-based companies. It's that lack of availability of risk capital that sometimes causes the IP to end up in foreign hands. That's one of the areas.
Another area is looking at the commercialization talent that is required. This is beyond the engineers and the developers that we're looking at. One thing about our ecosystem that I think holds back the growth of these sectors is the lack of executives who live in Canada who actually have experience in some of these advanced industries and in growing companies to $100 million, $500 million or $1 billion in revenue. Some work and some focus are needed on the executive level and on the mid-management level and above, the commercialization talent. I think there is a big gap in the innovation spectrum in how we are actually able to provide that support.
One of the last ones is on some of the regulatory processes and environments that exist to help our companies and some of the rules that help our companies to be able to compete globally. Even at the health side, it's about being able to have a regulatory environment that is sought after globally, like the FDA is, such that when companies are approved here, they can be viewed as approved globally.